Quick search
Advanced search in
Field to searchTerm
Add rule
Download Results
29 research outcomes, page 1 of 3
  • Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    L. Yu. Grivtsova; T. Yu. Mushkarina; V. V. Lunin; P. A. Zeynalova;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    The article considers the features and possibilities of flow cytometric diagnostics of plasma cell neoplasms, taking into account the classification of lymphoid and hematopoietic tissue tumors of the World Health Organization, revision of 2017 and the NCCN clinical reco...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    A. E. Pankratov; P. A. Zeynalova;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    A brief review focuses on the radiation diagnostics methods used in the examination of patients with myeloma and plasmacytoma. Modern imaging techniques, such as positron emission tomography combined with computed tomography (PET/CT) and magnetic resonance imaging, faci...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    A. S. Khudovekova; Ya. A. Rudenko; A. E. Dorosevich;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Multiple myeloma is a tumor of plasma cells, one of the most common malignant blood diseases. It is preceded by a stage called monoclonal gammopathy of undetermined significance, from which true multiple myeloma develops in only a small percentage of cases. It was assum...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access Russian
    Authors:
    A. Yu. Smirnova; Yu. V. Dinikina; A. A. Tereshina; E. P. Evsutina; M. B. Belogurova;
    Persistent Identifiers
    Publisher: ABV-press

    Atypical hemolytic uremic syndrome is a rare disorder uncontrolled complement activation, which is classically manifested by anemia, thrombocytopenia and renal failure. Extrarenal manifestations are observed in 20 % of patients, most of which are associated with damage ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    I. S. Piskunova; T. N. Moiseeva; L. S. Al-Radi; L. V. Plastinina; S. R. Goryacheva;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Cytopenia commonly occurs in case of chronic lymphocytic leukemia. It can either precede the diagnosis of chronic lymphocytic leukemia or appear at any time during the disease. Autoimmune hemolytic anemia, immune thrombocytopenia, and partial red cell aplasia are most o...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access Russian
    Authors:
    E. P. Evsyutina; Yu. V. Dinikina; A. Yu. Smirnova; E. E. Fedulova; A. A. Tereshina; M. M. Kirichenko; K. A. Morozov; I. I. Gorelov; A. K. Latypov; I. N. Menshugin; ...
    Persistent Identifiers
    Publisher: ABV-press

    The article presents the case of successful extracorporeal membrane oxygenation in severe acute respiratory distress syndrome in a child with malignant brain tumor. This method can be used in children with oncological diseases, taking into account the underlying disease...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    D. A. Morgacheva; Yu. V. Dinikina; Yu. K. Toshina; M. B. Belogurova;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Infectious complications remain one of the most significant problem associated with anticancer therapy in oncological patients. Cytotoxic, radiation and antibacterial therapy induce dysbiosis and gastrointestinal mucosal barrier injury. These changes lead to the mucosit...

    Add to ORCIDorcid
  • Bone metastasis is one of the most common manifestations of advanced malignant process. Many tumors, especially breast, prostate and lung cancer, multiple myeloma, are characterized by a high incidence of bone damage (up to 7080 %) and clinical complications. Intense pa...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    Yu. S. Korkina; T. T. Valiev;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Nowadays due to modern risk-adapted treatment protocols high survival rates have been achieved in patients with aggressive B-cell lymphomas, even at stages III–IV these indicators overrun 90 %. Mainly these successes were associated with the inclusion of rituximab in th...

    Add to ORCIDorcid
29 research outcomes, page 1 of 3